A detailed history of Intech Investment Management LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 113,307 shares of ARDX stock, worth $665,112. This represents 0.01% of its overall portfolio holdings.

Number of Shares
113,307
Previous 166,529 31.96%
Holding current value
$665,112
Previous $652,000 4.14%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$3.92 - $6.64 $208,630 - $353,394
-53,222 Reduced 31.96%
113,307 $625,000
Q2 2025

Aug 08, 2025

BUY
$3.28 - $5.51 $68,971 - $115,864
21,028 Added 14.45%
166,529 $652,000
Q1 2025

May 20, 2025

BUY
$4.91 - $6.36 $224,769 - $291,148
45,778 Added 45.91%
145,501 $714,000
Q4 2024

Feb 10, 2025

BUY
$4.49 - $6.85 $171,944 - $262,320
38,295 Added 62.34%
99,723 $515,000
Q3 2024

Nov 08, 2024

BUY
$5.28 - $7.57 $324,339 - $465,009
61,428 New
61,428 $423,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $908M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.